Werth, B. J., Zhang, R., Beltran, I. A. B., Penewit, K., Waalkes, A., Holmes, E. A., . . . Xu, L. (2025). Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-resistance or seesaw effect with other antimicrobials. Journal of Antimicrobial Chemotherapy (JAC), 80(4), 1108. https://doi.org/10.1093/jac/dkaf042
Chicago Style (17th ed.) CitationWerth, Brian J., Rutan Zhang, Ismael A Barreras Beltran, Kelsi Penewit, Adam Waalkes, Elizabeth A. Holmes, Stephen J. Salipante, and Libin Xu. "Simulated Exposures of Oritavancin in in Vitro Pharmacodynamic Models Select for Methicillin-resistant Staphylococcus Aureus with Reduced Susceptibility to Oritavancin but Minimal Cross-resistance or Seesaw Effect with Other Antimicrobials." Journal of Antimicrobial Chemotherapy (JAC) 80, no. 4 (2025): 1108. https://doi.org/10.1093/jac/dkaf042.
MLA (9th ed.) CitationWerth, Brian J., et al. "Simulated Exposures of Oritavancin in in Vitro Pharmacodynamic Models Select for Methicillin-resistant Staphylococcus Aureus with Reduced Susceptibility to Oritavancin but Minimal Cross-resistance or Seesaw Effect with Other Antimicrobials." Journal of Antimicrobial Chemotherapy (JAC), vol. 80, no. 4, 2025, p. 1108, https://doi.org/10.1093/jac/dkaf042.